Sponsors today are preparing for global studies around the world to assess the safety, tolerability and efficacy of an IMP but striking the right balance is key for every study. Clinical trials which often involves thousands of patients, across multiple sites throughout the world, keeping pace with demand, while actively avoiding product waste, is a difficult balance to master. To get the balance right, sponsors need to effectively forecast patient demand and plan production and distribution activity accordingly.

For one sponsor, preparing for a global phase 2b study to assess the safety, tolerability and efficacy of a biologic IMP, developed for the treatment of liver disease, striking the right balance was key. By embracing a technology-enabled approach to demand forecasting during the planning stage of its clinical trial, this sponsor achieved bigger picture visibility over its clinical supply chain and was able to successfully optimise operations, reduce risk and deliver study closure on time and on budget. SupplyWise made the very best use of the sponsor’s available material, click the link below to find out more.